Skip to main content

Table 3 Summary characteristics by treatment status among HIV-1 infected participants with viral load ≥ 1000 copies/ml

From: The HIV care continuum and HIV-1 drug resistance among female sex workers: a key population in Guinea-Bissau

 

Treatment naivea (n = 53)

ART expereriencedb (n = 22)

Treatment Naive vs ART experienced

p-value

Age

30 (24–35)

42 (30–46)

.002c

HIV-1/2 dual-infected

4 (7.6%)

5 (22.7%)

0.07d

CD4 cells/mm3

584 (373–787)

432 (184–726)

.17c

HIV-1 VL copies/ml

25,461 (5649–59,182)

7130 (2707–21,771)

.01c

Previous diagnosis

14 (27.5%)

22 (100.0%)

NA

Non-mutated virus

48 (90.6%)

11 (50.0%)

 

Detectable resistance

5 (9.4%)

11 (50.0%)

< .001d

NNRTI only

3 (5.7%)

4 (18.2%)

NA

NRTI only

2 (3.8%)

2 (9.1%)

NA

NRTI + NNRTI

0 (0.0%)

4 (18.1%)

NA

PI minor

0 (0.0%)

1 (4.6%)

NA

  1. Data are n (%) or median (IQR)
  2. ART antiretroviral therapy, NNRTI non-nucleoside reverse transcriptase inhibitors, NRTI nucleoside reverse transcriptase inhibitor, NA not applicable, PI protease inhibitors, VL viral load
  3. aIncluding 3 seroincident individuals
  4. bIncluding 3 individuals with previous ART use
  5. cMann–Whitney test U test
  6. dChi Square test